Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pharmacokinetic Study of Therapeutic Plasma Exchange

NCT: NCT07756242 · NOT_YET_RECRUITING

NCT IDNCT07756242
StatusNOT_YET_RECRUITING
Start Date2026-11
Completion2028-02
SponsorUniversity of Chicago (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to characterize the pharmacokinetics of one or more ICIs during and after TPE/PLEX in patients with severe irAEs.

Frequently Asked Questions

What is Pharmacokinetic Study of Therapeutic Plasma Exchange?

Pharmacokinetic Study of Therapeutic Plasma Exchange is a clinical trial registered under NCT07756242. Current status: NOT_YET_RECRUITING.

What is the status of NCT07756242?

The current status of NCT07756242 (Pharmacokinetic Study of Therapeutic Plasma Exchange) is: NOT_YET_RECRUITING.

When did Pharmacokinetic Study of Therapeutic Plasma Exchange start?

Pharmacokinetic Study of Therapeutic Plasma Exchange started on 2026-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑